IMNN: R&D Day Highlights Potential for IMNN-001…

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update R&D Day Highlights Potential for IMNN-001 On November 10, 2025, ...
TMCnet

IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment

(Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, will host an R&D Day on Monday, November 10, 2025 at 8:00 a.m. ET in New York City featuring ...
TMCnet

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights

Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart ...
Hosted on MSN

GCP Infra Declares Quarterly Dividend, Reinforcing Commitment to Shareholder Returns

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. GCP Infra Invt Shs GBP ( (GB:GCP)) has ...
BioSpace

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF

TX45 improved both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH‑HFrEF”) TX45 was well tolerated ...
The Virginian-Pilot

Trial begins Monday in case brought by Richneck Elementary schoolteacher shot by 6-year-old student

NEWPORT NEWS — A jury trial will begin Monday in the case of the teacher at Richneck Elementary School who was shot by a 6-year-old student in early 2023. Abby Zwerner was sitting at a reading table ...